Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus. (Q41103590)
scientific article published on June 1997
Language:
(P31) (Q13442814)
(P50) (Q50551511)
(Q62568676)
(Q50551503)
(Q44941865)
(Q13578863)
(P304) 324-328
(P407) (Q1860)
(P433) 2-3
(P478) 410
(P577) Sunday, June 1, 1997
(P921) (Q6844)
(P1433) (Q1388051)
(P1476) "Conversion of 2',3'-dideoxyadenosine (ddA) and 2',3'-didehydro-2',3'-dideoxyadenosine (d4A) to their corresponding aryloxyphosphoramidate derivatives markedly potentiates their activity against human immunodeficiency virus and hepatitis B virus" (language: en)
(P2093) J Balzarini
J Kruining
O Wedgwood
S Aquaro
M Witvrouw
R Heijtink
(P2860) (Q42200557)
(Q43458802)
(Q28368026)
(Q41455578)
(Q41199145)
(Q42556146)
(Q41175526)
(Q42288008)
(Q41693868)
(Q28378931)
(Q57637285)
(Q71781040)
other details
description scientific article published on June 1997

External Links